Investment News
January 14, 2022
AI Drug Discovery Platform Insilico Medicine Announces $255 Million in Series C Funding
The massive round is reflective of a recent breakthrough for the company: proof that its AI-based platform can create a new target for a disease, develop a bespoke molecule to address it, and begin the clinical trial process.
.png)